Literature DB >> 36058962

The Role of MARK ERK1/2 and p38 in Regulation of Functions of Neural Stem Cells and Neuroglia under Conditions of β-Amyloid-Induced Neurodegeneration.

G N Zyuz'kov1, L A Miroshnichenko2, A V Chaikovsky2, L Yu Kotlovskaya2.   

Abstract

The role of ERK1/2 and p38 in the realization of the growth potential of neural stem cells and secretion of neurotrophic growth factors by glial cells was studied using in vitro model of β-amyloid-induced neurodegeneration. It was shown that amyloid-β fragment 25-35 significantly inhibits the cell cycle progression of neural stem cells against the background of stimulation of their differentiation and reduced production of growth factors by neuroglia. The inhibitory role of ERK1/2 and p38 in relation to the proliferative activity of neural stem cells and the secretory activity of glial elements was revealed. ERK1/2 and p38 inhibitors increased proliferation of progenitor cells of the nervous tissue and reduced the intensity of their specialization, as well as stimulated production of growth factors by neuroglial cells under conditions of simulated β-amyloid-induced neurodegeneration.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; intracellular signal transduction; mitogen-activated protein kinases; neural stem cells; neuroglia

Mesh:

Substances:

Year:  2022        PMID: 36058962      PMCID: PMC9441322          DOI: 10.1007/s10517-022-05561-9

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.737


  10 in total

1.  Amyloid-β1-42 dynamically regulates the migration of neural stem/progenitor cells via MAPK-ERK pathway.

Authors:  Zhu Wang; Yantian Chen; Xueyi Li; Pinky Sultana; Ming Yin; Zejian Wang
Journal:  Chem Biol Interact       Date:  2018-11-03       Impact factor: 5.192

2.  Neuronal and Glial Differentiation of Human Neural Stem Cells Is Regulated by Amyloid Precursor Protein (APP) Levels.

Authors:  Raquel Coronel; María Lachgar; Adela Bernabeu-Zornoza; Charlotte Palmer; Marta Domínguez-Alvaro; Ana Revilla; Inmaculada Ocaña; Andrés Fernández; Alberto Martínez-Serrano; Eva Cano; Isabel Liste
Journal:  Mol Neurobiol       Date:  2018-06-07       Impact factor: 5.590

3.  Specific Features of Intracellular Signal Transduction in the Regulation of Functions of Neural Stem Cells and Committed Neuronal Progenitors.

Authors:  G N Zyuz'kov; L A Miroshnichenko; T Yu Polyakova; V V Zhdanov; E V Simanina; L A Stavrova; M G Danilets
Journal:  Bull Exp Biol Med       Date:  2021-03-16       Impact factor: 0.804

4.  Somatic APP gene recombination in Alzheimer's disease and normal neurons.

Authors:  Ming-Hsiang Lee; Benjamin Siddoway; Gwendolyn E Kaeser; Igor Segota; Richard Rivera; William J Romanow; Christine S Liu; Chris Park; Grace Kennedy; Tao Long; Jerold Chun
Journal:  Nature       Date:  2018-11-21       Impact factor: 49.962

Review 5.  Alzheimer's disease: Recent treatment strategies.

Authors:  Miguel Vaz; Samuel Silvestre
Journal:  Eur J Pharmacol       Date:  2020-09-15       Impact factor: 4.432

Review 6.  Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease.

Authors:  Tomris Ozben; Serkan Ozben
Journal:  Clin Biochem       Date:  2019-04-04       Impact factor: 3.281

7.  Targeting cAMP-pathway in Regeneration-competent Cells of Nervous Tissue: Potential to Create a Novel Drug for Treatment of Ethanol-induced Neurodegeneration.

Authors:  Gleb Nikolaevich Zyuz'kov; Larisa Arkad Evna; Tatyana Yur Evna Polykova; Elena Vladislavovna Simanina; Larisa Alexandrovna Stavrova
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2021

8.  Role of MAPK ERK1/2 and p38 in the Regulation of Secretory Functions of Different Populations of Neuroglia in Ethanol-Induced Neurodegeneration.

Authors:  G N Zyuz'kov; L A Miroshnichenko; T Yu Polyakova; V V Zhdanov; E V Simanina; L A Stavrova; A A Churin; T I Fomina
Journal:  Bull Exp Biol Med       Date:  2021-10-28       Impact factor: 0.804

9.  Stem Cell Therapy for Alzheimer's Disease.

Authors:  Fabin Han; Jianzhong Bi; Liyan Qiao; Ottavio Arancio
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  A case of xenon inhalation therapy for respiratory failure and neuropsychiatric disorders associated with COVID-19.

Authors:  Vladimir Vasil'evich Udut; Sergei Alexandrovich Naumov; Diana Nikolaevna Evtushenko; Elena Vladimirovna Udut; Sergei Sergeevich Naumov; Gleb Nikolaevich Zyuz'kov
Journal:  EXCLI J       Date:  2021-10-28       Impact factor: 4.068

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.